Where Are We and Where to Next?—The Future of Perianal Crohn’s Disease Management
Sulak Anandabaskaran, L Hanna, Nusrat Iqbal, Laura Constable, Phil Tozer, Ailsa Hart
Abstract
Perianal fistulizing Crohn's Disease (pCD) affects about 25% of patients with Crohn's Disease (CD). It remains a difficult entity to manage with a therapeutic ceiling of treatment success despite improving medical and surgical management. The refractory nature of the disease calls for an imminent need to better understand its immunopathogenesis and classification to better streamline our treatment options. In this article, we overview the current state of pCD management and discuss where the future of its management may lie.
Topics & Concepts
MedicineCrohn's diseaseDiseaseDisease managementInflammatory bowel diseaseRefractory (planetary science)Intensive care medicineCrohn diseaseInternal medicineAstrobiologyParkinson's diseasePhysicsAnorectal Disease Treatments and OutcomesInflammatory Bowel DiseaseDiverticular Disease and Complications